Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect? [1]

Journal of Clinical Oncology

Volumn 24, Issue 32, 2006, Pages 5170-5171

  Schagen, Sanne B ^a   Van Dam, Frits S A M ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CLINICAL PRACTICE; COGNITION; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; LETTER; PRIORITY JOURNAL; PUBLICATION; ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; FATIGUE; FEMALE; FOLLOW UP; METHODOLOGY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NOTE; PSYCHOLOGICAL ASPECT; RISK FACTOR; SAMPLE SIZE;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COGNITION DISORDERS; FATIGUE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RESEARCH DESIGN; RISK FACTORS; SAMPLE SIZE;

EID: 34247208052     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.07.8303     Document Type: Letter

References (16)

1. Ahles TA, Saykin AJ, Furstenberg CT, et al: Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20:485-493, 2002
2. Bender CM, Sereika SM, Berga SL, et al: Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology 15:422-430, 2005
3. Brezden CB, Phillips KA, Abdolell M, et al: Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 18:2695-2701, 2000
4. Castellon SA, Ganz PA, Bower JE, et al: Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 26:955-969, 2004
5. Jenkins V, Shilling V, Deutsch G, et al: A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 94:828-834, 2006
6. Schagen SB, van Dam FS, Muller MJ, et al: Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85:640-650, 1999
7. Shilling V, Jenkins V, Morris R, et al: The effects of adjuvant chemotherapy on cognition in women with breast cancer-preliminary results of an observational longitudinal study. Breast 14:142-150, 2005
8. Tchen N, Juffs HG, Downie FP, et al: Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 21:4175-4183, 2003
9. van Dam FS, Schagen SB, Muller MJ, et al: Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90:210-218, 1998
10. Wefel JS, Lenzi R, Theriault R, et al: 'Chemobrain' in breast carcinoma? A prologue. Cancer 101:466-475, 2004
11. Wefel JS, Lenzi R, Theriault RL, et al: The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal trial. Cancer 100:2292-2299, 2004
12. Wieneke MH, Dienst ER: Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology 4:61-66, 1995
13. Fan HG, Houede-Tchen N, Yi QL, et al: Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol 23:8025-8032, 2005
14. Faust D, Fogel BS: The development and initial validation of a sensitive bedside cognitive screening test. J Nerv Ment Dis 177:25-31, 1989
15. Vardy J, Wong K, Yi QL, et al: Assessing cognitive function in cancer patients. Support Care Cancer doi:10.1007/S00520.006.0037.6
16. Salthouse TA, Schroeder DH, Ferrer E: Estimating retest effects in longitudinal assessments of cognitive functioning in adults between 18 and 60 years of age. Dev Psychol 40:813-822, 2004